Biohaven Ltd. (BHVN)

Latest Insider Confidence Score

2026Q1

55.6
Bullish

Company insider confidence (by quarter)

2022Q3 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Childs John W Director 4,222,825 Nov 17, 2025
Bailey Gregory Director 2,020,071 Nov 17, 2025
Coric Vlad CEO 1,906,713 Nov 17, 2025
Mehta Kishan Director 125,000 Oct 5, 2022
Clark George C. VP, Chief Accounting Officer 65,595 Nov 18, 2025

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 27, 2026 Mar 3, 2026 Buten Matthew CFO Neutral 52.5 - 0.00% ✗ -
Feb 27, 2026 Mar 3, 2026 Gentile Kimberly SVP, Clinical Operations Neutral 52.5 - 0.00% ✗ -
Feb 27, 2026 Mar 3, 2026 Clark George C. VP, Chief Accounting Officer Neutral 52.5 - 0.00% ✗ -
Feb 27, 2026 Mar 3, 2026 Car Bruce Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Feb 27, 2026 Mar 3, 2026 Coric Vlad CEO Neutral 52.5 - 0.00% ✗ -
Jan 5, 2026 Jan 7, 2026 Gentile Kimberly SVP, Clinical Operations Sell 46.3 -1,956 -1.93% ✗ $19.4K
Jan 5, 2026 Jan 7, 2026 Buten Matthew CFO Sell 46.3 -2,594 -1.31% ✗ $25.8K
Jan 5, 2026 Jan 7, 2026 Coric Vlad CEO Sell 47.5 -7,430 -0.19% ✗ $73.8K
Jan 5, 2026 Jan 7, 2026 Car Bruce Chief Scientific Officer Sell 46.3 -2,381 -5.94% ✗ $23.6K
Jan 5, 2026 Jan 7, 2026 Clark George C. VP, Chief Accounting Officer Sell 46.3 -1,117 -1.27% ✗ $11.1K
Nov 17, 2025 Nov 18, 2025 Clark George C. VP, Chief Accounting Officer Buy 95.0 +17,000 24.78% ✗ $144.8K
Nov 13, 2025 Nov 17, 2025 Bailey Gregory Director Buy 100.0 +400,000 24.69% ✗ $3M
Nov 13, 2025 Nov 17, 2025 CHILDS JOHN W Director Buy 100.0 +3,333,333 50.94% ✗ $25M
Nov 13, 2025 Nov 17, 2025 Coric Vlad CEO Buy 100.0 +666,666 20.99% ✗ $5M
May 5, 2025 May 7, 2025 Antonijevic Irina Director Neutral 52.5 - 0.00% ✗ -
May 5, 2025 May 7, 2025 Heffernan Michael Thomas Director Neutral 52.5 - 0.00% ✗ -
May 5, 2025 May 7, 2025 Bailey Gregory Director Neutral 52.5 - 0.00% ✗ -
May 5, 2025 May 7, 2025 Mehta Kishan Director Neutral 52.5 - 0.00% ✗ -
May 5, 2025 May 7, 2025 GREGORY JULIA P Director Neutral 52.5 - 0.00% ✗ -
May 5, 2025 May 7, 2025 CHILDS JOHN W Director Neutral 52.5 - 0.00% ✗ -
May 5, 2025 May 7, 2025 HUGIN ROBERT J Director Neutral 52.5 - 0.00% ✗ -
Mar 4, 2025 Mar 5, 2025 CHILDS JOHN W Director Buy 75.0 +32,700 0.50% ✗ $996.2K
Apr 22, 2024 Mar 5, 2025 CHILDS JOHN W Director Buy 92.5 +73,170 3.35% ✗ $3M
Jan 5, 2025 Jan 7, 2025 Car Bruce Chief Scientific Officer Sell 42.5 -2,331 -6.28% ✗ $90.1K
Jan 5, 2025 Jan 7, 2025 Gentile Kimberly SVP, Clinical Operations Sell 42.5 -1,956 -1.96% ✗ $75.6K
Jan 5, 2025 Jan 7, 2025 Clark George C. VP, Chief Accounting Officer Sell 46.3 -1,117 -1.61% ✗ $43.2K
Jan 5, 2025 Jan 7, 2025 Buten Matthew CFO Sell 42.5 -2,561 -1.31% ✗ $99K
Jan 5, 2025 Jan 7, 2025 Coric Vlad CEO Sell 45.0 -6,805 -0.21% ✗ $262.9K
Dec 30, 2024 Dec 31, 2024 CHILDS JOHN W Director Buy 70.0 +29,000 0.45% ✗ $1M
Oct 2, 2024 Oct 3, 2024 CHILDS JOHN W Director Buy 67.5 +21,052 0.33% ✗ $1000K
Oct 2, 2024 Oct 3, 2024 Coric Vlad CEO Buy 75.0 +21,052 0.67% ✗ $1000K
Sep 24, 2024 Sep 25, 2024 Bailey Gregory Director Buy 65.0 +5,000 0.31% ✗ $221K
Jul 18, 2024 Jul 19, 2024 CHILDS JOHN W Director Buy 70.0 +28,400 0.44% ✗ $1M
Jun 17, 2024 Jun 20, 2024 Car Bruce Chief Scientific Officer Buy 100.0 +30,000 1258.92% ✗ $1M
May 30, 2024 May 31, 2024 CHILDS JOHN W Director Buy 67.5 +28,000 0.44% ✗ $996.2K
May 13, 2024 May 15, 2024 Bailey Gregory Director Buy 75.0 +15,000 0.94% ✗ $512.9K
May 13, 2024 May 14, 2024 CHILDS JOHN W Director Buy 70.0 +28,500 0.45% ✗ $1M
Apr 30, 2024 May 2, 2024 Mehta Kishan Director Neutral 52.5 - 0.00% ✗ -
Apr 30, 2024 May 2, 2024 Heffernan Michael Thomas Director Neutral 52.5 - 0.00% ✗ -
Apr 30, 2024 May 2, 2024 GREGORY JULIA P Director Neutral 52.5 - 0.00% ✗ -
Apr 30, 2024 May 2, 2024 HUGIN ROBERT J Director Neutral 52.5 - 0.00% ✗ -
Apr 30, 2024 May 2, 2024 Antonijevic Irina Director Neutral 52.5 - 0.00% ✗ -
Apr 30, 2024 May 2, 2024 CHILDS JOHN W Director Neutral 52.5 - 0.00% ✗ -
Apr 30, 2024 May 2, 2024 Bailey Gregory Director Neutral 52.5 - 0.00% ✗ -
Apr 24, 2024 Apr 25, 2024 Bailey Gregory Director Buy 85.0 +25,503 1.62% ✗ $999.2K
Apr 22, 2024 Apr 23, 2024 Bailey Gregory Director Buy 92.5 +48,780 3.20% ✗ $2M
Apr 22, 2024 Apr 23, 2024 CHILDS JOHN W Director Buy 93.8 +195,121 3.16% ✗ $8M
Apr 22, 2024 Apr 23, 2024 Coric Vlad CEO Buy 92.5 +121,951 4.03% ✗ $5M
Apr 5, 2024 Apr 5, 2024 CHILDS JOHN W Director Neutral 55.0 +2,091 0.10% ✗ -
Apr 5, 2024 Apr 5, 2024 Coric Vlad CEO Neutral 47.5 +694 0.02% ✗ -
Mar 8, 2024 Mar 8, 2024 CHILDS JOHN W Director Neutral 60.0 +19,412 0.32% ✗ -
Mar 8, 2024 Mar 8, 2024 Coric Vlad CEO Neutral 60.0 +6,472 0.21% ✗ -
Jan 8, 2024 Jan 10, 2024 CHILDS JOHN W Director Neutral 67.5 +48,505 0.79% ✗ -
Jan 8, 2024 Jan 10, 2024 Coric Vlad CEO Neutral 67.5 +16,168 0.54% ✗ -
Jan 2, 2024 Jan 4, 2024 Clark George C. VP, Chief Accounting Officer Neutral 52.5 - 0.00% ✗ -
Jan 2, 2024 Jan 4, 2024 Car Bruce Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Jan 2, 2024 Jan 4, 2024 Gentile Kimberly SVP, Clinical Operations Neutral 52.5 - 0.00% ✗ -
Jan 2, 2024 Jan 4, 2024 Buten Matthew CFO Neutral 52.5 - 0.00% ✗ -
Jan 2, 2024 Jan 4, 2024 Coric Vlad CEO Neutral 52.5 - 0.00% ✗ -
Dec 29, 2023 Dec 29, 2023 Antonijevic Irina Director Sell 20.0 -11,000 -81.27% ✗ $459.7K
Nov 2, 2023 Nov 6, 2023 Buten Matthew CFO Neutral 52.5 - 0.00% ✗ -
Nov 2, 2023 Nov 6, 2023 Coric Vlad CEO Neutral 52.5 - 0.00% ✗ -
Nov 2, 2023 Nov 6, 2023 Clark George C. VP, Chief Accounting Officer Neutral 52.5 - 0.00% ✗ -
Nov 2, 2023 Nov 6, 2023 Gentile Kimberly SVP, Clinical Operations Neutral 52.5 - 0.00% ✗ -
Nov 2, 2023 Nov 6, 2023 Car Bruce Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Oct 5, 2023 Oct 10, 2023 CHILDS JOHN W Director Buy 96.3 +454,545 8.04% ✗ $10M
Oct 5, 2023 Oct 10, 2023 Coric Vlad CEO Buy 100.0 +454,545 17.86% ✗ $10M
Oct 5, 2023 Oct 6, 2023 Buten Matthew CFO Buy 97.5 +22,727 13.64% ✗ $500K
Oct 4, 2023 Oct 6, 2023 Bailey Gregory Director Buy 85.0 +17,817 1.18% ✗ $402.1K
Aug 30, 2023 Aug 31, 2023 CHILDS JOHN W Director Buy 75.0 +50,000 0.89% ✗ $922.2K
Aug 4, 2023 Aug 7, 2023 CHILDS JOHN W Director Buy 87.5 +100,000 1.82% ✗ $2M
May 2, 2023 May 4, 2023 Bailey Gregory Director Neutral 52.5 - 0.00% ✗ -
May 2, 2023 May 4, 2023 Mehta Kishan Director Neutral 52.5 - 0.00% ✗ -
May 2, 2023 May 4, 2023 GREGORY JULIA P Director Neutral 52.5 - 0.00% ✗ -
May 2, 2023 May 4, 2023 Antonijevic Irina Director Neutral 52.5 - 0.00% ✗ -
May 2, 2023 May 4, 2023 CHILDS JOHN W Director Neutral 52.5 - 0.00% ✗ -
May 2, 2023 May 4, 2023 Heffernan Michael Thomas Director Neutral 52.5 - 0.00% ✗ -
May 2, 2023 May 4, 2023 HUGIN ROBERT J Director Neutral 52.5 - 0.00% ✗ -
Oct 25, 2022 Mar 22, 2023 CHILDS JOHN W Director Buy 100.0 +3,709,819 206.53% ✗ $39M
Nov 18, 2022 Clark George C. VP, Chief Accounting Officer Neutral 52.5 - 0.00% ✗ -
Oct 31, 2022 Nov 1, 2022 Coric Vlad CEO Buy 85.0 +25,800 1.02% ✗ $412K
Oct 28, 2022 Oct 31, 2022 Coric Vlad CEO Buy 95.0 +141,930 5.97% ✗ $2.1M
Oct 25, 2022 Oct 26, 2022 Bailey Gregory Director Buy 100.0 +200,000 15.29% ✗ $2.1M
Oct 25, 2022 Oct 26, 2022 Coric Vlad CEO Buy 100.0 +853,380 56.01% ✗ $9M
Oct 25, 2022 Oct 26, 2022 CHILDS JOHN W Director Buy 100.0 +3,900,000 217.12% ✗ $41M
Oct 25, 2022 Oct 26, 2022 Buten Matthew CFO Buy 100.0 +142,857 600.34% ✗ $1.5M
Oct 25, 2022 Oct 26, 2022 GREGORY JULIA P Director Buy 95.0 +9,523 59.00% ✗ $100K
Oct 3, 2022 Oct 12, 2022 Coric Vlad CEO Neutral 52.5 - 0.00% ✗ -
Oct 3, 2022 Oct 12, 2022 HUGIN ROBERT J Director Sell 22.5 -12,959 -50.00% ✗ $97.2K
Oct 3, 2022 Oct 12, 2022 Heffernan Michael Thomas Director Sell 22.5 -9,699 -38.99% ✗ $72.7K
Oct 5, 2022 Oct 6, 2022 Coric Vlad CEO Buy 100.0 +485,775 119.68% ✗ $5M
Oct 5, 2022 Oct 5, 2022 CHILDS JOHN W Director Buy 100.0 +274,141 18.01% ✗ $2.5M
Oct 3, 2022 Oct 5, 2022 Coric Vlad CEO Neutral 90.0 +461,470 80.08% ✗ -
Oct 3, 2022 Oct 5, 2022 CHILDS JOHN W Director Neutral 90.0 +1,517,500 32917.57% ✗ -
Oct 3, 2022 Oct 5, 2022 Heffernan Michael Thomas Director Sell 26.3 -3,847 -15.46% ✗ $41.3K
Oct 3, 2022 Oct 5, 2022 Gentile Kimberly SVP, Clinical Operations Sell 20.0 -19,541 -11.65% ✗ $262.4K
Oct 3, 2022 Oct 5, 2022 Antonijevic Irina Director Neutral 90.0 +2,535 100.00% ✗ -
Oct 3, 2022 Oct 5, 2022 Car Bruce Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Oct 3, 2022 Oct 5, 2022 Biohaven Pharmaceutical Holding Co Ltd. 10% Owner Neutral 52.5 - 0.00% ✗ -
Oct 3, 2022 Oct 5, 2022 Mehta Kishan Director Sell 22.5 -5,459 -13.75% ✗ $82K